A new CDC campaign "Free Mind" addresses rising drug overdoses and mental health issues among youth, offering vital resources ...

Results from the Phase III NEPTUNUS-1 (NCT05350072) and NEPTUNUS-2 (NCT05349214) trials demonstrated that ianalumab ...

The journal is standing by the study, which looked into the safety of vaccines that have aluminum ingredients.

Accelerated approval was based on results from the Phase Ib Beamion-LUNG 1 trial (NCT04886804), which showed a 75% objective ...

Today, imaging often exists independently of molecular insights, trial data, treatment decisions, and longitudinal patient ...

Executives from DIA, Ranjini Prithviraj and Sudip Parikh discuss documents the FDA released that further detail the agency’s implementation plan for its Software Precertification Pilot Program.

Pharmaceutical Executive delivers strategic insights for pharma leaders, covering commercialization, market access, R&D, and leadership to drive success.

Himanshu Jain is Business Consulting Director, Life Sciences and Healthcare Strategy, NTT DATA Services.

Vinay Prasad, MD, MPH, who was appointed to run the FDA's Center for Biologics Evaluation and Research (CBER) in May, then ...

The importance of expanding your pharma sales forecasting horizon beyond the US. Learn how to effectively navigate country-specific regulatory red flags.

Radella Pharmaceuticals reveals promising Phase 1b trial results for MD-18, showcasing significant weight loss and ...

Gene Mack, CEO of Gain Therapeutics, outlines the company’s strategic approach to advancing GT-02287 through potential collaborations and financing options as they await critical Parkinson’s disease ...